Correction: Combination of Itacitinib or Parsaclisib with Pembrolizumab in Patients with Advanced Solid Tumors: A Phase I Study
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Munster P, Iannotti N, Cho D, Kirkwood J, Villaruz L, Gibney G
. Combination of Itacitinib or Parsaclisib with Pembrolizumab in Patients with Advanced Solid Tumors: A Phase I Study. Cancer Res Commun. 2023; 3(12):2572-2584.
PMC: 10729644.
DOI: 10.1158/2767-9764.CRC-22-0461.
View